Comparison of Azvudine and Nirmatrelvir/Ritonavir and Combined Use in Patients with COVID-19.

Authors:
Hu CY; Cui WS; Lei Y; Tang YW; Zhang YY and 8 more

Journal:
Infect Drug Resist

Publication Year: 2023

DOI:
10.2147/IDR.S433186

PMCID:
PMC10750493

PMID:
38148771

Journal Information

Full Title: Infect Drug Resist

Abbreviation: Infect Drug Resist

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors have no competing interests to declare that are relevant to the content of this article."

Evidence found in paper:

"This work was funded by the National Nature Science Foundation of China (Grant No. 81970038 and 8227004) and the Science and Technology Projects in Guangzhou, China (SL2022A04J00473)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025